| SARS-CoV-2 RNA detected in blood products from patients with COVID-19 is not associated with infectious virus MI Andersson, CV Arancibia-Carcamo, K Auckland, JK Baillie, E Barnes, ... Wellcome open research 5, 181, 2020 | 179 | 2020 |
| Insights from deep sequencing of the HBV genome—unique, tiny, and misunderstood AL McNaughton, V D’Arienzo, MA Ansari, SF Lumley, M Littlejohn, ... Gastroenterology 156 (2), 384-399, 2019 | 128 | 2019 |
| Illumina and Nanopore methods for whole genome sequencing of hepatitis B virus (HBV) AL McNaughton, HE Roberts, D Bonsall, M de Cesare, J Mokaya, ... Scientific reports 9 (1), 7081, 2019 | 115 | 2019 |
| Hepatitis B virus infection as a neglected tropical disease GA O’Hara, AL McNaughton, T Maponga, P Jooste, P Ocama, R Chilengi, ... PLoS neglected tropical diseases 11 (10), e0005842, 2017 | 112 | 2017 |
| A blind spot? Confronting the stigma of hepatitis B virus (HBV) infection-A systematic review J Mokaya, AL McNaughton, L Burbridge, T Maponga, G O'Hara, ... Wellcome open research 3, 29, 2018 | 107 | 2018 |
| Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020 CP Thompson, NE Grayson, RS Paton, JS Bolton, J Lourenco, ... Eurosurveillance 25 (42), 2000685, 2020 | 85 | 2020 |
| The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection CM Pley, AL McNaughton, PC Matthews, J Lourenço BMJ Global Health 6 (1), 2021 | 83 | 2021 |
| A systematic review of hepatitis B virus (HBV) drug and vaccine escape mutations in Africa: A call for urgent action J Mokaya, AL McNaughton, MJ Hadley, A Beloukas, AM Geretti, ... PLoS neglected tropical diseases 12 (8), e0006629, 2018 | 76 | 2018 |
| Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta‐analysis C Campbell, T Wang, AL McNaughton, E Barnes, PC Matthews Journal of viral hepatitis 28 (3), 493-507, 2021 | 75 | 2021 |
| Hepatitis B virus seroepidemiology data for Africa: Modelling intervention strategies based on a systematic review and meta-analysis AL McNaughton, J Lourenço, PA Bester, J Mokaya, SF Lumley, U Obolski, ... PLoS medicine 17 (4), e1003068, 2020 | 64 | 2020 |
| Analysis of genomic-length HBV sequences to determine genotype and subgenotype reference sequences AL McNaughton, PA Revill, M Littlejohn, PC Matthews, MA Ansari Journal of General Virology 101 (3), 271-283, 2020 | 60 | 2020 |
| Identification of immune correlates of fatal outcomes in critically ill COVID-19 patients J Youngs, NM Provine, N Lim, HR Sharpe, A Amini, YL Chen, J Luo, ... PLoS Pathogens 17 (9), e1009804, 2021 | 57 | 2021 |
| Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis A Artenie, J Stone, H Fraser, D Stewart, C Arum, AG Lim, AL McNaughton, ... The lancet Gastroenterology & hepatology 8 (6), 533-552, 2023 | 55 | 2023 |
| Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses AL McNaughton, RS Paton, M Edmans, J Youngs, J Wellens, P Phalora, ... JCI insight 7 (13), e156372, 2022 | 40 | 2022 |
| Extending treatment eligibility for chronic hepatitis B virus infection AL McNaughton, M Lemoine, C van Rensburg, PC Matthews Nature Reviews Gastroenterology & Hepatology 18 (3), 146-147, 2021 | 39 | 2021 |
| Hepatitis B virus adaptation to the CD8+ T cell response: consequences for host and pathogen SF Lumley, AL McNaughton, P Klenerman, KA Lythgoe, PC Matthews Frontiers in Immunology 9, 1561, 2018 | 39 | 2018 |
| Evidence of tenofovir resistance in chronic hepatitis B virus (HBV) infection: An observational case series of South African adults J Mokaya, TG Maponga, AL McNaughton, M Van Schalkwyk, S Hugo, ... Journal of Clinical Virology 129, 104548, 2020 | 35 | 2020 |
| Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort E Adland, G Jesuthasan, L Downs, V Wharton, G Wilde, AL McNaughton, ... BMC Infectious Diseases 18, 1-10, 2018 | 34 | 2018 |
| Mixed genotype hepatitis C infections and implications for treatment AL McNaughton, EC Thomson, K Templeton, RN Gunson, ECMW Leitch Hepatology 59 (3), 1209-1209, 2014 | 33 | 2014 |
| HBV vaccination and PMTCT as elimination tools in the presence of HIV: insights from a clinical cohort and dynamic model AL McNaughton, J Lourenço, L Hattingh, E Adland, S Daniels, A Van Zyl, ... BMC medicine 17, 1-15, 2019 | 31 | 2019 |
Philippa C. MatthewsThe Francis Crick Institute | University College London在 crick.ac.uk 的电子邮件经过验证